Diisocyanate asthma: Clinical aspects and immunopathogenesis

International Immunopharmacology

Volumn 2, Issue 2-3, 2002, Pages 213-224

  Redlich, Carrie A ^b   Karol, Meryl H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Adduct; Airway hyperreactivity; Asthma; Diisocyanate; Immunopathogenesis; Occupational; Thiol reactions

Indexed keywords

ACTIN; DIHYDRODIOL DEHYDROGENASE; DIPHENYLMETHANE 4,4' DIISOCYANATE; GLUCOSE REGULATED PROTEIN; HEXAMETHYLENE DIISOCYANATE; ISOCYANIC ACID DERIVATIVE; ISOPHORONE DIISOCYANATE; KERATIN; SERUM ALBUMIN; TOLUENE DIISOCYANATE; TUBULIN; UNCLASSIFIED DRUG;

BRONCHUS HYPERREACTIVITY; CHEMICAL INTERACTION; CLINICAL FEATURE; DIAGNOSTIC TEST; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; RISK FACTOR; SKIN; TOXICITY;

ANIMALS; ASTHMA; HUMANS; RISK FACTORS; TOLUENE 2,4-DIISOCYANATE;

EID: 0036145399     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00174-6     Document Type: Review

References (83)

1. Occupational asthma due to isocyanates
2. Overview of diisocyanate occupational asthma
3. Respiratory health surveillance in a toluene diisocyanate production unit, 1967-97: Clinical observations and lung function analyses
4. Occupational airway sensitizers: An overview on the respective literature
5. Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma
6. Isophorone diisocyanate induced respiratory disease (IPDI)
7. The role of the skin in the development of chemical respiratory hypersensitivity
8. Dermal contact with toluene diisocyanate (TDI) produces respiratory tract sensitivity in guinea pigs
9. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate
10. Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers
11. Comparison of sampling methods for monomer and polyisocyanates of 1,6-hexamethylene diisocyanate during spray finishing operations
12. Exposures to 1,6-hexamethylene diisocyanate during polyurethane spray painting in the U.S. Air Force
13. Persistence of toluene diisocyanate-induced asthma despite negligible workplace exposures
14. Isocyanate exposure and occupational asthma: A case-referent study
15. Urinary hexane diamine as an indicator of occupational exposure to hexamethylene diisocyanate
16. Development of immunoassays for biomonitoring of hexamethylene diisocyanate exposure
17. The immunology and prevention of isocyanate asthma: A model for low molecular weight asthma
18. Clinical evaluation, management, and prevention of work-related asthma
19. Immunologic responses to isocyanates in sensitized asthmatic subjects
20. Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents
21. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures
22. Can reactive airways dysfunction syndrome (RADS) transform into occupational asthma due to "sensitisation" to isocyanates?
23. Hypersensitivity pneumonitis (extrinsic allergic alveolitis) induced by isocyanates
24. Hypersensitivity pneumonitis-like reaction among workers exposed to diphenylmethane [correction to piphenylmethane] diisocyanate (MDI)
25. Bronchial hyperresponsiveness, airway inflammation and occupational asthma induced by toluene diisocyanate
26. Toluene diisocyanate-induced asthma without airway hyperresponsiveness
27. Current diagnostic methods for diisocyanate induced occupational asthma
28. Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians
29. Occupational asthma
30. Is the clinical history a satisfactory means of diagnosing occupational asthma?
31. Occupational lung disease: 8. The diagnosis of occupational asthma from serial measurements of lung function at and away from work
32. Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of European Academy of Allergy and Clinical Immunology
33. Occupational asthma: Validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge
34. Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma
35. Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate-induced asthma: A pilot study
36. Increase in non-specific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges
37. Follow-up of occupational asthma after removal from or diminution of exposure to the responsible agent: Relevance of the length of the interval from cessation of exposure
38. Occupational asthma, IgE and IgG
39. Occupational asthma and extrinsic alveolitis due to isocyanates: Current status and perspectives
40. Specific IgG, but not specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results
41. T cell receptor V beta gene segment expression in diisocyanate-induced occupational asthma
42. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma
43. Outcome of specific bronchial responsiveness to occupational agents after removal from exposure
44. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure
45. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma
46. Outcome determinants for isocyanate induced occupational asthma among compensation claimants
47. Respiratory sensitization to diphenyl-methane-4,4′-diisocyanate (MDI) in guinea pigs: Impact of particle size on induction and elicitation of response
48. What is the respiratory retention of inhaled hexamethylene diisocyanate?
49. Uptake and distribution of 14C during and following inhalation exposure to radioactive toluene diisocyanate
50. Autoradiographic analyses of guinea pig airway tissues following inhalation exposure to 14C-labeled methyl isocyanate
51. Cell and molecular biology of chemical asthma
52. 4-Hydroxy-2-nonenal increases gamma-glutamylcysteine synthetase gene expression in alveolar epithelial cells
53. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns
54. Formation, solvolysis, and transcarbamoylation reactions of bis(S-glutathionyl) adducts of 2,4- and 2,6-diisocyanatotoluene
55. Rapid reduction of intracellular glutathione in human bronchial epithelial cells exposed to occupational levels of toluene diisocyanate
56. Mechanisms and pathology of occupational asthma
57. Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene
58. Inhibition of cholinesterase activity by isocyanates
59. Toluene diisocyanate protein adducts in the bronchoalveolar lavage of guinea pigs exposed to vapors of the chemical
60. Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo
61. Immunohistochemical detection of toluene diisocyanate (TDI) adducts: I. Pulmonary tissue of guinea pigs following inhalation exposure
62. Airway isocyanate-adducts in asthma induced by exposure to hexamethylene diisocyanate
63. Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells
64. Mechanisms of occupational asthma
65. Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma
66. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma
67. Expression of interleukin IL-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI)
68. Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: Comparison with allergic asthma
69. Characterization of airway inflammation after repeated exposures to occupational agents
70. Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge
71. Immunologic aspects of isocyanate asthma: IL-1 beta, IL-3, IL-4, sIL2R, and sICAM-1
72. Indirect assessment of 4,4′-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin
73. The development of an animal model for TDI asthma
74. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate
75. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma
76. Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate
77. CD8 T cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate
78. HLA class II alleles in isocyanate-induced asthma
79. Association between toluene diisocyanate-induced asthma and DQB1 markers: A possible role for aspartic acid at position 57
80. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma
81. No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma
82. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure